Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 69.65

-2.6%

Nov 3 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2059)	2/4/2008 2:51:35 PM
From: Jibacoa	Read Replies (2) of 3722

ADL Has traded as high as $3.90 It was up 15.72% at its intraday H, but is now back to the $3.37 level.<g> bigcharts.marketwatch.com The reason for its earlier spike was because it announced today that its Jade's subsidiary received an "updated third party valuation" of its land use rights, & its plant and buildings have now been reappraised for $21.8M, which is significantly > the FY2007 book value of those assets.<g> Its Jade subsidiary in China, makes large volume injection fluids, tablets and other products.(It has licenses for 133 products.) It also manufactures 107 generic & over the counter pharmaceutical products. As previously mentioned, some "analysts" have put a "target" for ADL around $28, but I have lowered mine to $6 for the next Yr.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next